Comment from Center for Reproductive Rights
AnonymousOpposeAdvocacy
Summary: The Center for Reproductive Rights opposes the citizen petitions requesting that the FDA impose additional regulations on mifepristone based on claims of environmental contamination. They argue that these claims lack scientific and legal basis, citing previous FDA findings that confirm the drug's safety and lack of significant environmental impact.
See attached updated comment from the Center for Reproductive Rights. This comment replaces a previous comment from the Center for Reproductive Rights with the tracking number mp6-144i-53me.